Susan Grandy,1 Eirini Palaka,2 Nicolas Guzman,3 Alicia Dunn,4 Eric T. Wittbrodt,5 Fredric O. Finkelstein6
1Biopharmaceuticals Global Market Access, AstraZeneca, Gaithersburg, MD, USA2Biopharmaceuticals Global Market Access, AstraZeneca, Cambridge, UK3Global Medicines Development, AstraZeneca, Gaithersburg, MD, USA4Global Corporate Affairs, AstraZeneca, Gaithersburg, MD, USA5Biopharmaceuticals Medical Unit, AstraZeneca, Gaithersburg, MD, USA6Yale University, New Haven, CT, USA
Running title : US patient perspectives of anemia in CKD
Correspondence : Dr Susan Grandy, BioPharmaceuticals Business Unit, AstraZeneca, One MedImmune Way, Gaithersburg, MD 20878. Tel: +1 302 723-1523; Email: susan.grandy@astrazeneca.com
Abstract word count: 293
Word count: 2865 (5000 max)